United States Prevention, Pesticides EPA712-C-96-195
Environmental Protection and Toxic Substances June 1996
Agency (7101)
&EPA Health Effects Test
Guidelines
OPPTS 870.2400
Acute Eye Irritation
"Public Draft'
-------
INTRODUCTION
This guideline is one of a series of test guidelines that have been
developed by the Office of Prevention, Pesticides and Toxic Substances,
United States Environmental Protection Agency for use in the testing of
pesticides and toxic substances, and the development of test data that must
be submitted to the Agency for review under Federal regulations.
The Office of Prevention, Pesticides and Toxic Substances (OPPTS)
has developed this guideline through a process of harmonization that
blended the testing guidance and requirements that existed in the Office
of Pollution Prevention and Toxics (OPPT) and appeared in Title 40,
Chapter I, Subchapter R of the Code of Federal Regulations (CFR), the
Office of Pesticide Programs (OPP) which appeared in publications of the
National Technical Information Service (NTIS) and the guidelines pub-
lished by the Organization for Economic Cooperation and Development
(OECD).
The purpose of harmonizing these guidelines into a single set of
OPPTS guidelines is to minimize variations among the testing procedures
that must be performed to meet the data requirements of the U. S. Environ-
mental Protection Agency under the Toxic Substances Control Act (15
U.S.C. 2601) and the Federal Insecticide, Fungicide and Rodenticide Act
(7U.S.C. I36,etseq.).
Public Draft Access Information: This draft guideline is part of a
series of related harmonized guidelines that need to be considered as a
unit. For copies: These guidelines are available electronically from the
EPA Public Access Gopher (gopher.epa.gov) under the heading "Environ-
mental Test Methods and Guidelines" or in paper by contacting the OPP
Public Docket at (703) 305-5805 or by e-mail:
guidelines@epamail.epa.gov.
To Submit Comments: Interested persons are invited to submit com-
ments. By mail: Public Docket and Freedom of Information Section, Office
of Pesticide Programs, Field Operations Division (7506C), Environmental
Protection Agency, 401 M St. SW., Washington, DC 20460. In person:
bring to: Rm. 1132, Crystal Mall #2, 1921 Jefferson Davis Highway, Ar-
lington, VA. Comments may also be submitted electronically by sending
electronic mail (e-mail) to: guidelines@epamail.epa.gov.
Final Guideline Release: This guideline is available from the U.S.
Government Printing Office, Washington, DC 20402 on The Federal Bul-
letin Board. By modem dial 202-512-1387, telnet and ftp:
fedbbs.access.gpo.gov (IP 162.140.64.19), or call 202-512-0132 for disks
or paper copies. This guideline is also available electronically in ASCII
and PDF (portable document format) from the EPA Public Access Gopher
(gopher.epa.gov) under the heading "Environmental Test Methods and
Guidelines."
-------
OPPTS 870.2400 Acute eye irritation.
(a) Scope—(1) Applicability. This guideline is intended to meet test-
ing requirements of both the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA) (7 U.S.C. 136, et seq.) and the Toxic Substances
Control Act (TSCA) (15 U.S.C. 2601).
(2) Background. The source material used in developing this har-
monized OPPTS test guideline are OPPTS 798.4500 Primary Eye Irrita-
tion; OPP 81-4 Acute Eye Irritation—Rabbit (Pesticide Assessment Guide-
lines, Subdivision F—Hazard Evaluation; Human and Domestic Animals)
EPA report 540/09-82-025, 1982; and OECD 405 Acute Eye Irritation/
Corrosion.
(b) Purpose. (1) In the assessment and evaluation of the toxic charac-
teristics of a substance, determination of the irritant and/or corrosive ef-
fects on eyes of mammals is an important initial step. Information derived
from this test serves to indicate the existence of possible hazards likely
to arise from exposure of the eyes and associated mucous membranes to
the test substance.
(2) Data on primary eye irritation are required by 40 CFR 158.340
to support the registration of each manufacturing-use product and end-use
product. (See § 158.50 to determine whether these data must be submitted
and which purity/grade of the test substance should be tested.)
(c) Definitions. The definitions in section 3 of TSCA and in 40 CFR
Part 792—Good Laboratory Practice Standards (GLP) apply to this test
guideline. The following definitions also apply to this test guideline.
Eye corrosion is the production of irreversible tissue damage in the
eye following application of a test substance to the anterior surface of
the eye.
Eye irritation is the production of reversible changes in the eye fol-
lowing the application of a test substance to the anterior surface of the
eye.
(d) Principle of the test method. The substance to be tested is ap-
plied in a single dose to one of the eyes in each of several experimental
animals; the untreated eye is used to provide control information. The de-
gree of irritation/corrosion is evaluated and scored at specified intervals
and is fully described to provide a complete evaluation of the effects. The
duration of the study should be sufficient to permit a full evaluation of
the reversibility or irreversibility of the effects observed. The period of
observation should be at least 72 h, but need not exceed 21 days. Animals
showing severe and enduring signs of distress and pain may need to be
killed in a humane fashion.
-------
(e) Initial considerations. (1) Strongly acidic or alkaline substances,
for example, with a demonstrated pH of 2 or less or 11.5 or greater, need
not be tested owing to their predictable corrosive properties. Buffer capac-
ity should also be taken into account.
(2) Materials which have demonstrated definite corrosion or severe
irritation in a dermal study need not be further tested for eye irritation.
It may be presumed that such substances will produce similarly severe
effects in the eyes.
(3) Results from well validated and accepted in vitro test systems
may serve to identify corrosives or irritants such that the test material need
not be tested in vivo.
(f) Test procedures—(1) Animal selection—(i) Species and strain.
A variety of experimental animals has been used, but it is recommended
that testing should be performed using healthy adult albino rabbits. Com-
monly used laboratory strains should be used. If another mammalian spe-
cies is used, the tester should provide justification/reasoning for its selec-
tion.
(ii) Number of animals. A single animal should be considered if
marked effects are anticipated. If the results of this test in one animal
suggest the test substance to be a severe irritant (reversible effect) or corro-
sive (irreversible effect) to the eye using the procedure described, further
tests may not need to be performed. In cases other than a single animal
test, at least three animals should be used. Occasionally, further testing
in additional animals may be appropriate to clarify equivocal responses.
(2) Dose level. For testing liquids, a dose of 0.1 mL is recommended.
In testing solids, pastes, and particulate substances, the amount used should
have a volume of 0.1 mL, or a weight of not more than 100 mg (the
weight must always be recorded). If the test material is solid or granular,
it should be ground to a fine dust. The volume of particulates should be
measured after gently compacting them (e.g. by tapping the measuring
container). To test a substance contained in a pressurized aerosol container,
the eye should be held open and the test substance administered in a single
burst of about 1 sec from a distance of 10 cm directly in front of the
eye. The dose may be estimated by weighing the container before and
after use. Care should be taken not to damage the eye. Pump sprays should
not be used but instead the liquid should be expelled and 0.1 mL collected
and instilled into the eye as described for liquids. For volatile substances,
the dose may be estimated by weighing the container before and after
use.
(3) Examination of eyes prior to test. Both eyes of each experi-
mental animal provisionally selected for testing should be examined within
24 h before testing starts by the same procedure to be used during the
-------
test examination. Animals showing eye irritation, ocular defects, or pre-
existing corneal injury should not be used.
(4) Application of the test substance, (i) The test substance should
be placed in the conjunctival sac of one eye of each animal after gently
pulling the lower lid away from the eyeball. The lids are then gently held
together for about 1 sec in order to limit loss of the material. The other
eye, which remains untreated, serves as a control. If it is thought that the
substance may cause extreme pain, local anesthetic may be used prior to
instillation of the test substance. The type and concentration of the local
anesthetic should be carefully selected to ensure that no significant dif-
ferences in reaction to the test substance will result from its use. The con-
trol eye should be similarly anesthetized.
(ii) The eyes of the test animals should not be washed out for
24 h following instillation of the test substance. At 24 h, a washout may
be used if considered appropriate.
(iii) For some substances shown to be irritating by this test, additional
testing using animals with eyes washed soon after instillation of the sub-
stance may be indicated. Half a minute after instillation, the eyes of the
animals are washed with water for 30 sec, using a volume and velocity
of flow which will not cause injury.
(5) Observation period. The duration of the observation period is
at least 72 h, and should not be fixed rigidly, but should be sufficient
to evaluate fully the reversibility or irreversibility of the effects observed.
The observation period normally need not exceed 21 days after instillation.
(6) Clinical examination and scoring, (i) The eyes should be exam-
ined at 1, 24, 48, and 72 h. If there is no evidence of irritation at 72
h, the study may be ended. Extended observation (e.g. at 7 and 21 days)
may be necessary if there is persistent corneal involvement or other ocular
irritation in order to determine the progress of the lesions and their revers-
ibility or irreversibility. In addition to the observations of the cornea, iris
and conjunctivae, any other lesions which are noted should be recorded
and reported. The grades of ocular reaction using the following table
should be recorded at each examination.
Grades for Ocular Lesions
Cornea
Opacity: Degree of density (area most dense taken for reading). No ulceration or
opacity 0
Scattered or diffuse areas of opacity (other than slight dulling of normal luster),
details of iris clearly visible 1
Easily discernible translucent area, details of iris slightly obscured 2
Nacrous area, no details or iris visible, size of pupil barely discernible 3
Opaque cornea, iris not discernible through the opacity 4
-------
Grades for Ocular Lesions
Iris
Normal 0
Markedly deepened rugae, congestion, swelling moderate circumcorneal hyper-
emia, or injection, any of these or combination of any thereof, iris still reacting to
light (sluggish reaction is positive) 1
No reaction to light, hemorrhage, gross destruction (any or all of these) 2
Conjunctivae
Redness (refers to palpebral and bulbar conjunctivae, excluding cornea and iris).
Blood vessels normal 0
Some blood vessels definitely hyperemic (injected) 1
Diffuse, crimson color, individual vessels not easily discernible 2
Diffuse beefy red 3
Chemosis (refers to lids and/or nictitating membranes)
No swelling 0
Any swelling above normal (includes nictitating membranes) 1
Obvious swelling with partial eversion of lids 2
Swelling with lids about half closed 3
Swelling with lids more than half-closed 4
(ii) Examination of reactions can be facilitated by use of a binocular
loupe, hand slit-lamp, biomicroscope, or other suitable device. After re-
cording the observations at 24 h, the eyes of any or all rabbits may be
further examined with the aid of fluorescein.
(iii) The grading of ocular responses is subject to various interpreta-
tions. To promote harmonization and to assist testing laboratories and
those involved in making and interpreting the observations, an illustrated
guide in grading eye irritation should be used.
(g) Data and reporting—(1) Data summary. Data should be sum-
marized in tabular form, showing for each individual animal the irritation
scores at the designated observation time; a description of the degree and
nature of irritation; the presence of serious lesions and any effects other
than ocular which were observed.
(2) Evaluation of the results. The ocular irritation scores should be
evaluated in conjunction with the nature and reversibility or otherwise of
the responses observed. The individual scores do not represent an absolute
standard for the irritant properties of a material. They should be viewed
as reference values and are only meaningful when supported by a full
description and evaluation of the observations.
(3) Test report. In addition to the reporting requirements as specified
under 40 CFR part 792, subpart J, the following specific information
should be reported:
(i) Physical nature and, where appropriate, concentration and pH
value for the test substance.
(ii) Species and strain of test animal.
-------
(iii) Tabulation of irritant/corrosive response data for each individual
animal at each observation time point (e.g. 1, 24, 48, and 72 h).
(iv) Description of any lesions observed.
(v) Narrative description of the degree and nature of irritation or cor-
rosion observed.
(vi) Description of the method used to score the irritation at 1, 24,
48, and 72 h (e.g. hand slit-lamp, biomicroscope, fluorescein).
(vii) Description of any nonocular effects noted.
(h) References. The following references should be consulted for ad-
ditional background information on this test guideline
(1) Buehler, E.V. andNewmann, E.A. A Comparison of Eye Irritation
in Monkeys and Rabbits. Toxicology and Applied Pharmacology 6:701-
710 (1964).
(2) Draize, J.H. Dermal Toxicity. Appraisal of the Safety of Chemicals
in Foods, Drugs and Cosmetics. The Association of Food and Drug Offi-
cials of the United States (1959) 3rd printing 1975, pp. 49-52.
(3) Draize, J.H. et al. Methods for the study of irritation and toxicity
of substances applied topically to the skin and mucous membranes. Jour-
nal of Pharmacology and Experimental Therapeutics. 83:377-390 (1944).
(4) Loomis, T.A. Essentials of Toxicology. Lea and Febicer, Philadel-
phia 3rd ed. 1978 pp. 226-232.
(5) Kay, J.H. and Calandra, J.C., Interpretation of eye irritation tests.
Journal of the Society of Cosmetic Chemists 13:281-289 (1962).
(6) National Academy of Sciences. Principles and Procedures for
Evaluating the Toxicity of Household Substances. A report prepared by
the Committee for the revision of NAS Publication 1138, under the aus-
pices of the Committee on Toxicology, National Research Council, Na-
tional Academy of Sciences, Washington, DC (1977).
(7) World Health Organization. Part I. Environmental Health Criteria
6. Principles and Methods for Evaluating the Toxicity of Chemicals. World
Health Organization, Geneva (1978).
------- |